Westmead Clinical School, The University of Sydney, Sydney, New South Wales, Australia.
Department of Gastroenterology and Hepatology, Westmead Hospital, Sydney, New South Wales, Australia.
Endoscopy. 2018 Jan;50(1):52-62. doi: 10.1055/s-0043-119215. Epub 2017 Oct 11.
Non-lifting large laterally spreading colorectal lesions (LSLs) are challenging to resect endoscopically and often necessitate surgery. A safe, simple technique to treat non-lifting LSLs endoscopically with robust long-term outcomes has not been described.
In this single-center prospective observational study of consecutive patients referred for endoscopic mucosal resection (EMR) of LSLs ≥ 20 mm, LSLs not completely resectable by snare because of non-lifting underwent standardized completion of resection with cold-forceps avulsion and adjuvant snare-tip soft coagulation (CAST). Scheduled surveillance colonoscopies were performed at 4 - 6 months (SC1) and 18 months (SC2). Primary outcomes were endoscopic evidence of adenoma clearance and avoidance of surgery. The secondary outcome was safety.
From January 2012 to October 2016, 540 lifting LSLs (82.2 %) underwent complete snare excision at EMR. CAST was required for complete removal in 101 non-lifting LSLs (17.8 %): 63 naïve non-lifting lesions (NNLs; 62.7 %) and 38 previously attempted non-lifting lesions (PANLs; 37.3 %). PANLs were smaller ( < 0.001) and more likely to be non-granular ( = 0.001) than the lifting LSLs. NNLs were of similar size ( = 0.77) and morphology ( = 0.10) to the lifting LSLs. CAST was successful in all cases and adverse events were comparable to lifting LSLs resected by complete snare excision. Recurrence at SC1 was comparable for PANLs (15.2 %) and lifting LSLs (15.3 %; = 0.99), whereas NNLs recurred more frequently (27.5 %; = 0.049); however, surgery was no more common for either type of non-lifting LSL than for lifting LSLs.
CAST is a safe, effective, and surgery-sparing therapy for the majority of non-lifting LSLs. It is easy to use, inexpensive, and does not require additional equipment.
非提升型侧向扩展结直肠病变(LSLs)内镜下切除具有挑战性,往往需要手术治疗。目前尚未描述一种安全、简单的内镜治疗非提升型 LSL 的技术,且该技术具有可靠的长期疗效。
本研究为单中心前瞻性观察性研究,连续纳入因 LSLs >20mm 而接受内镜黏膜切除术(EMR)的患者,因非提升而无法完全通过圈套器切除的 LSLs 采用冷钳撕除法和辅助圈套器尖端电凝(CAST)完成标准切除。在 4-6 个月(SC1)和 18 个月(SC2)进行计划的结肠镜随访。主要结局是内镜下腺瘤清除的证据和避免手术。次要结局是安全性。
2012 年 1 月至 2016 年 10 月,540 例提升型 LSLs(82.2%)在 EMR 中完全切除圈套器切除。101 例非提升型 LSLs(17.8%)需要进行 CAST 完全切除:63 例初治非提升型病变(NNLs;62.7%)和 38 例既往尝试非提升型病变(PANLs;37.3%)。PANLs 较小(P<0.001),且更可能是非颗粒状(P=0.001),而非提升型 LSLs 为颗粒状。NNLs 的大小(P=0.77)和形态(P=0.10)与提升型 LSLs 相似。所有病例均成功完成 CAST,不良事件与完全圈套器切除的提升型 LSLs 相当。SC1 时 PANLs(15.2%)和提升型 LSLs(15.3%;P=0.99)的复发率相似,而 NNLs 的复发率更高(27.5%;P=0.049);然而,非提升型 LSLs 的手术率并不比提升型 LSLs 更常见。
CAST 是一种安全、有效且避免手术的治疗大多数非提升型 LSL 的方法。它易于使用,价格低廉,且不需要额外的设备。